Quantcast

Latest Systems biology Stories

2011-06-10 07:30:00

CARLSBAD, Calif., June 10, 2011 /PRNewswire/ -- Life Technologies Corporation has signed an exclusive license agreement for novel technology that enables synthetic biologists to effectively program and control the genetic circuitry in engineered pathways and organisms. This technology, discovered by the inventors while at Martin-Luther-Universitat Halle-Wittenberg in Germany, provides the ability to target and regulate expression within the genome and will enable researchers to more...

2011-06-06 07:30:00

DENVER, June 6, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced it has entered into a non-exclusive co-marketing and reselling agreement with PREMIER Biosoft International (Palo Alto, CA) to advance lipidomics research. Waters will offer PREMIER Biosoft's SimLipid® informatics platform for sale with Waters® ACQUITY UPLC® and high-resolution, exact mass SYNAPT® and XEVO® mass...

2011-05-25 14:44:55

Cutting-edge 'Omics' tools transform skin and hair biology to illuminate new pathways to advanced beauty and grooming innovation Procter & Gamble (NYSE: PG) today unveiled its pioneering efforts in the breakthrough field of 'Omics' that is set to solve the molecular puzzles of beauty and leapfrog innovations in this space. Twenty-one years after the start of the Human Genome Project in 1990, the science of genomics has come of age and led to a new era of 'Omics'-based research. This...

2011-05-18 13:18:48

Cell signaling networks tied to diabetes and cancer Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders. The article was deemed a "Paper of the Week" by and will be on the cover of the...

2011-05-12 06:30:00

SAN DIEGO, May 12, 2011 /PRNewswire/ -- GT Life Sciences, Inc., (GT) a privately held biotechnology company announced today the issuance of Patent No. 7,856,317 for "SYSTEMS AND METHODS FOR CONSTRUCTING GENOMIC-BASED PHENOTYPIC MODELS" by the United States Patent and Trademark Office. The '317 patent has a priority date of June 14, 2002 and contains broad, novel claims to computer systems and complex modeling processes by which scientists may use computational models to create scalable...

2011-03-21 16:45:52

Rigorous bioinformatic analysis of the strengths, limitations published in Nature Biotechnology A software package designed to minimize the potential risks of synthetic biology for the nation's defense and security is now available to the gene synthesis industry and synthetic biology community in an open-source format. Virginia Tech has licensed GenoTHREAT, a software tool that helps detect the use of synthetic DNA as bioterrorism agents. Developed as an open-source project by a team led by...

2011-03-17 21:08:28

Systems biology is a holistic approach to the study of how a living organism emerges from the interactions of the individual elements that make up its constituent cells. Embracing a broad range of disciplines, this field of science that is just beginning to come into public prominence holds promise for advances in a number of important areas, including safer, more effective pharmaceuticals, improved environmental remediation, and clean, green, sustainable energy. However, the most profound...

2011-03-14 17:05:00

SEATTLE, March 14, 2011 /PRNewswire/ -- In a bold plan for scientific expansion and leadership for the future, Seattle Biomedical Research Institute (Seattle BioMed) today announced that it will integrate a systems biology approach with its global infectious disease research. Systems biology pioneer and renowned immunologist Alan Aderem, Ph.D., will join the Institute as Director to guide the implementation of this revolutionary approach, positioning Seattle BioMed as the only institute...

2011-03-08 15:23:04

Metabolomics is a post-genomic research field for analysis of low molecular weight compounds in biological systems, and its approaches offer an analysis of metabolite level changes in biological samples. Recently, metabolomic method has shown great potentials in identifying the new diagnostic markers and therapeutic targets for cancers. However, metabolomic studies on cancer metastasis remain scarce. A research article to be published on February 14, 2011 in the World Journal of...

2011-03-02 09:02:00

CAMBRIDGE, Mass., March 2, 2011 /PRNewswire/ -- Berg Biosystems, LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary of Via Science, today announced that they have entered into a joint venture named MAP Biosystems, LLC (MAP) to combine their unique capabilities to accelerate advancements in critical biomedical research. MAP will utilize a combination of Berg's novel Interrogative Biology(TM) drug discovery platform, and GNS's patented supercomputer-driven REFS(TM) modeling and...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related